Skip to Content

b 171 (Mefloquine 250 mg)

Pill imprint b 171 has been identified as Mefloquine hydrochloride 250 mg.

Mefloquine is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial quinolines. There is no proven risk in humans during pregnancy. Mefloquine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mefloquine hydrochloride 250 mg b 171  Front
Mefloquine hydrochloride 250 mg b 171  Back
Mefloquine hydrochloride 250 mg b 171
Mefloquine hydrochloride
b 171
250 mg
13.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
corn starch
lactose monohydrate
magnesium stearate
microcrystalline cellulose
poloxamer 188
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5407 A-S Medication Solutions, LLC (repackager)
23490-5858 Palmetto State Pharmaceuticals Inc (repackager)
21695-0449 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.